You are logged in as an admin user. This page is cached for performance until Wed, 10 Aug 2022 22:44:19 GMT. Preview latest contents by clicking Refresh.
Logout

Breaking News: Shaping the future of AMD and DME

Track:
Co-Developed Symposium
What:
Co-Developed Symposium | Symposium élaboré conjointement
When:
6:30 AM, Sunday 12 Jun 2022 (1 hour 30 minutes)
Breaks:
Continental Breakfast    07:00 AM to 08:00 AM (1 hour)
How:
Discussion:
0

LEARNING OBJECTIVES

At the end of this symposium, participants will be able to:

  • Identify the critical unmet needs in neovascular AMD and DME management
  • Demonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME management
  • Examine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DME
  • Apply new insights from multi-modal imaging platforms to optimize diagnosis and management in the retina clinic

CanMEDS Roles: Medical Expert, Scholar

SCIENTIFIC PLANNING COMMITTEE
Varun Chaudhary, MD, Chair
Arif Samad, MD
Sarah Mullen, MD
 

This symposium was co-developed with the Canadian Ophthalmological Society and Roche, in order to achieve scientific integrity, objectivity and balance.

Moderator
2022 Planning Committee - Retina
Keynote speaker
Keynote Speaker
Speaker
Keynote Speaker | Conférencier Invité

Sub Sessions

Talk | Exposé
RetinaCo-Developed Symposium
Moderator Varun Chaudhary | Panelist Sunir Garg | Panelist Wai-Ching Lam | Panelist Michael Ip
Panel | Table ronde
RetinaCo-Developed Symposium
Speaker Michael Ip
RetinaCo-Developed Symposium
Panelist Michael Ip | Panelist Sunir Garg | Panelist Wai-Ching Lam | Moderator Varun Chaudhary
RetinaCo-Developed Symposium
Panelist Wai-Ching Lam | Panelist Michael Ip | Panelist Sunir Garg | Moderator Varun Chaudhary
RetinaCo-Developed Symposium

Share this